Clinical course in young patients with sporadic Creutzfeldt-Jakob disease.

Standard

Clinical course in young patients with sporadic Creutzfeldt-Jakob disease. / Boesenberg, Constanze; Schulz-Schaeffer, Walter J; Meissner, Bettina; Kallenberg, Kai; Bartl, Mario; Heinemann, Uta; Krasnianski, Anna; Stoeck, Katharina; Varges, Daniela; Windl, Otto; Kretzschmar, Hans A; Zerr, Inga.

in: ANN NEUROL, Jahrgang 58, Nr. 4, 4, 2005, S. 533-543.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Boesenberg, C, Schulz-Schaeffer, WJ, Meissner, B, Kallenberg, K, Bartl, M, Heinemann, U, Krasnianski, A, Stoeck, K, Varges, D, Windl, O, Kretzschmar, HA & Zerr, I 2005, 'Clinical course in young patients with sporadic Creutzfeldt-Jakob disease.', ANN NEUROL, Jg. 58, Nr. 4, 4, S. 533-543. <http://www.ncbi.nlm.nih.gov/pubmed/16037975?dopt=Citation>

APA

Boesenberg, C., Schulz-Schaeffer, W. J., Meissner, B., Kallenberg, K., Bartl, M., Heinemann, U., Krasnianski, A., Stoeck, K., Varges, D., Windl, O., Kretzschmar, H. A., & Zerr, I. (2005). Clinical course in young patients with sporadic Creutzfeldt-Jakob disease. ANN NEUROL, 58(4), 533-543. [4]. http://www.ncbi.nlm.nih.gov/pubmed/16037975?dopt=Citation

Vancouver

Boesenberg C, Schulz-Schaeffer WJ, Meissner B, Kallenberg K, Bartl M, Heinemann U et al. Clinical course in young patients with sporadic Creutzfeldt-Jakob disease. ANN NEUROL. 2005;58(4):533-543. 4.

Bibtex

@article{dc9d056d033e4737a2687e4de13efc4b,
title = "Clinical course in young patients with sporadic Creutzfeldt-Jakob disease.",
abstract = "Sporadic Creutzfeldt-Jakob disease (sCJD) is a rare neurodegenerative disease with the greatest incidence occurring in patients between 60 and 70 years old. Younger patients may also be affected. In this study, we used all case material available from 52 patients with sCJD aged 50 years or younger at disease onset, who were identified between 1993 and 2003 in Germany. The objective of this study was to describe the psychiatric and neurological features of these young patients with emphasis on the different codon 129 genotypes and PrP types, and to compare them with elder patients with sCJD and patients with variant CJD. We also gave particular attention to electroencephalogram, magnetic resonance imaging, and 14-3-3 results, as well as to the neuropathological lesion profile. The clinical syndrome in young patients differs from elder patients with CJD with respect to clinical signs, disease duration, technical investigations, and neuropathological lesion profile. The psychiatric symptoms in young patients with sCJD are similar to the psychiatric symptoms expressed by patients with variant CJD; however, in contrast with the variant cases, young patients with sCJD experience development of prominent dementia early in the disease course.",
author = "Constanze Boesenberg and Schulz-Schaeffer, {Walter J} and Bettina Meissner and Kai Kallenberg and Mario Bartl and Uta Heinemann and Anna Krasnianski and Katharina Stoeck and Daniela Varges and Otto Windl and Kretzschmar, {Hans A} and Inga Zerr",
year = "2005",
language = "Deutsch",
volume = "58",
pages = "533--543",
journal = "ANN NEUROL",
issn = "0364-5134",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

RIS

TY - JOUR

T1 - Clinical course in young patients with sporadic Creutzfeldt-Jakob disease.

AU - Boesenberg, Constanze

AU - Schulz-Schaeffer, Walter J

AU - Meissner, Bettina

AU - Kallenberg, Kai

AU - Bartl, Mario

AU - Heinemann, Uta

AU - Krasnianski, Anna

AU - Stoeck, Katharina

AU - Varges, Daniela

AU - Windl, Otto

AU - Kretzschmar, Hans A

AU - Zerr, Inga

PY - 2005

Y1 - 2005

N2 - Sporadic Creutzfeldt-Jakob disease (sCJD) is a rare neurodegenerative disease with the greatest incidence occurring in patients between 60 and 70 years old. Younger patients may also be affected. In this study, we used all case material available from 52 patients with sCJD aged 50 years or younger at disease onset, who were identified between 1993 and 2003 in Germany. The objective of this study was to describe the psychiatric and neurological features of these young patients with emphasis on the different codon 129 genotypes and PrP types, and to compare them with elder patients with sCJD and patients with variant CJD. We also gave particular attention to electroencephalogram, magnetic resonance imaging, and 14-3-3 results, as well as to the neuropathological lesion profile. The clinical syndrome in young patients differs from elder patients with CJD with respect to clinical signs, disease duration, technical investigations, and neuropathological lesion profile. The psychiatric symptoms in young patients with sCJD are similar to the psychiatric symptoms expressed by patients with variant CJD; however, in contrast with the variant cases, young patients with sCJD experience development of prominent dementia early in the disease course.

AB - Sporadic Creutzfeldt-Jakob disease (sCJD) is a rare neurodegenerative disease with the greatest incidence occurring in patients between 60 and 70 years old. Younger patients may also be affected. In this study, we used all case material available from 52 patients with sCJD aged 50 years or younger at disease onset, who were identified between 1993 and 2003 in Germany. The objective of this study was to describe the psychiatric and neurological features of these young patients with emphasis on the different codon 129 genotypes and PrP types, and to compare them with elder patients with sCJD and patients with variant CJD. We also gave particular attention to electroencephalogram, magnetic resonance imaging, and 14-3-3 results, as well as to the neuropathological lesion profile. The clinical syndrome in young patients differs from elder patients with CJD with respect to clinical signs, disease duration, technical investigations, and neuropathological lesion profile. The psychiatric symptoms in young patients with sCJD are similar to the psychiatric symptoms expressed by patients with variant CJD; however, in contrast with the variant cases, young patients with sCJD experience development of prominent dementia early in the disease course.

M3 - SCORING: Zeitschriftenaufsatz

VL - 58

SP - 533

EP - 543

JO - ANN NEUROL

JF - ANN NEUROL

SN - 0364-5134

IS - 4

M1 - 4

ER -